Evidence-based care for alcohol use disorders is affordable

Journal of Studies on Alcohol

Volumn 65, Issue 4, 2004, Pages 521-529

  Corry, Justine ^a,b   Sanderson, Kristy ^a,c   Issakidis, Cathy ^a,b   Andrews, Gavin ^a,b   Lapsley, Helen ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; AUSTRALIA; CALCULATION; COST EFFECTIVENESS ANALYSIS; DISABILITY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH SURVEY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL CLASSIFICATION OF DISEASES INJURIES AND CAUSES OF DEATH TENTH REVISION; MENTAL HEALTH; MODEL; PATIENT CARE; PUBLIC HEALTH; TREATMENT OUTCOME; WELLBEING;

EID: 2642555033     PISSN: 0096882X     EISSN: None     Source Type: Journal    
DOI: 10.15288/jsa.2004.65.521     Document Type: Article

References (49)

1. ANDREWS, G., HENDERSON, S. AND HALL, W. Prevalence, comorbidity, disability and service utilisation: Overview of the Australian National Mental Health Survey. Brit. J. Psychiat. 178: 145-153, 2001a.
2. ANDREWS, G., ISSAKIDIS, C. AND CARTER, G. Shortfall in mental health service utilisation. Brit. J. Psychiat. 179: 417-425, 2001b.
3. ANDREWS, G., ISSAKIDIS, C., SANDERSON, K., CORRY, J. AND LAPSLEY, H. A comparison of the cost and effectiveness of treatment of ten mental disorders: Utilising survey data for public policy. Brit. J. Psychiat. 184: 526-533, 2004.
4. ANDREWS, G., SANDERSON, K., CORRY, J., ISSAKIDIS, C. AND LAPSLEY, H. Cost-effectivness of current and optimal treatment for schizophrenia. Brit. J. Psychiat. 183: 427-435, 2003.
5. ANDREWS, G., SLADE, T. AND ISSAKIDIS, C. Deconstructing current comorbidity: Data from the Australian National Survey of Mental Health and Well-Being. Brit. J. Psychiat. 181: 306-314, 2002.
6. BIJL, R.V. AND RAVELLI, A. Psychiatric morbidity, service use, and need for care in the general population: Results of the Netherlands Mental Health Survey and Incidence Study. Amer. J. Publ. Hlth 90: 602-607, 2000.
7. BUCKINGHAM, B., BURGESS, P., SOLOMON, S., PIRKIS, J. AND EAGAR, K. Developing a Casemix Classification for Mental Health Services, Vol. 1: Main Report, Canberra, Australia: Commonwealth Department of Health and Family Services, 1998.
8. CALMAN, K.C. The ethics of allocation of scarce health care resources: A view from the centre. J. Med. Ethics 20: 71-74, 1994.
9. CHANCELLOR, J.V., COYLE, D. AND DRUMMOND, M.F. Constructing health state preference values from descriptive quality of life outcomes: Mission impossible? Qual. Life Res. 6: 159-168, 1997.
10. COAST, J. Reprocessing data to form QALYs. Brit. Med. J. 305: 87-90, 1992.
11. COLLINS, D.J. AND LAPSLEY, H.M. Counting the Costs: Estimates of the Social Costs of Drug Abuse in Australia in 1998-9, Monograph Series No. 49, Canberra, Australia: Commonwealth Department of Health and Ageing, 2002.
12. COMMONWEALTH DEPARTMENT OF HEALTH AND AGED CARE. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners, November 1999, Canberra, Australia: Commonwealth Department of Health and Aged Care, 1999.
13. FEENEY, G.F., YOUNG, R.M., CONNOR, J.P., TUCKER, J. AND MCPHERSON, A. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: Are short-term treatment outcomes for alcohol dependence improved? Aust. New Zeal. J. Psychiat. 36: 622-628, 2002.
14. FLEMING, M.F., MUNDT, M.P., FRENCH, M.T., MANWELL, L.B., STAUFFACHER, E.A. AND BARRY, K.L. Brief physician advice for problem drinkers: Long-term efficacy and benefit-cost analysis. Alcsm Clin. Exp. Res. 26: 36-43, 2002.
15. GOLD, M.R., SIEGEL, J.E., RUSSELL, L.B. AND WEINSTEIN, M.C. (Eds.). Cost-Effectiveness in Health and Medicine, New York: Oxford Univ. Press, 1996.
16. GOLDMAN, H.H., GANJU, V., DRAKE, R.E., GORMAN, P., HOGAN, M., HYDE, P.S. AND MORGAN, O. Policy implications for implementing evidence-based practices. Psychiat. Serv. 52: 1591-1597, 2001.
17. HALL, W. AND TEESSON, M. Alcohol-use disorders: Who should be treated and how? In: ANDREWS, G. AND HENDERSON, S. (Eds.) Unmet Need in Psychiatry: Problems, Resources, Responses, New York: Cambridge Univ. Press, 2000, pp. 290-301.
18. HATZIANDREU, E.J., BROWN, R.E., REVICKI, D.A., TURNER, R., MARTINDALE, J., LEVINE, S. AND SIEGEL, J.E. Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. Pharmacoeconomics 5: 249-268, 1994.
19. HIRTH, R.A., CHERNEW, M.E., MILLER, E., FENDRICK, A.M. AND WEISSERT, W.G. Willingness to pay for a quality-adjusted life year: In search of a standard. Med. Dec. Making 20: 332-342, 2000.
20. HOLDER, H., LONGABAUGH, R., MILLER, W.R. AND RUBONIS, A.V. The cost effectiveness of treatment for alcoholism: A first approximation. J. Stud. Alcohol 52: 517-540, 1991.
21. IRVIN, J.E., BOWERS, C.A., DUNN, M.E. AND WANG, M.C. Efficacy of relapse prevention: A meta-analytic review. J. Cons. Clin. Psychol. 67: 563-570, 1999.
22. ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G. AND LAPSLEY, H. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychol. Med. 34: 19-35, 2004.
23. KESSLER, R.C., MCGONAGLE, K.A., ZHAO, S., NELSON, C.B., HUGHES, M., ESHLEMAN, S., WITTCHEN, H.-U. AND KENDLER, K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiat. 51: 8-19, 1994.
24. KESSLER, R.C., ZHAO, S., KATZ, S.J., KOUZIS, A.C., FRANK, R.G., EDLUND, M. AND LEAF, P. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Study. Amer. J. Psychiat. 156: 115-123, 1999.
25. LAUPACIS, S.M., FEENY, D., DETSKY, A.S. AND TUGWELL, P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. J. Can. Med. Assn 146: 473-481, 1992.
26. LAWRIE, S.M., SCOTT, A.I. AND SHARPE, M.C. Implementing evidence-based psychiatry: Whose responsibility? Brit. J. Psychiat. 178: 195-196, 2001.
27. LONNQVIST, J., SINTONEN, H., SYVALAHTI, E., APPELBERG, B., KOSKINEN, T., MANNIKKO, T., MEHTONEN, O.P., NAARALA, M., SIHVO, S. AND AUVINEN, J. ET AL. Antidepressant efficacy and quality of life in depression: A double-blind study with moclobemide and fluoxetine. Acta Psychiat. Scand. 89: 363-369, 1994.
28. MANDERSCHEID, R.W., RAE, D.S., NARROW, W.E., LOCKE, B.Z. AND REGIER, D.A. Congruence of service utilization estimates from the Epidemiologic Catchment Area Project and other sources. Arch. Gen. Psychiat. 50: 108-114, 1993.
29. MATHERS, C., VOS, T. AND STEVENSON, C. The Burden of Disease and Injury in Australia, Canberra, Australia: Australian Institute of Health and Welfare, 1999.
30. MELSE, J.M., ESSINK-BOT, M.L., KRAMERS, P.G. AND HOEYMANS, N. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Amer. J. Publ. Hlth 90: 1241-1247, 2000.
31. MOYER, A., FINNEY, J.W., SWEARINGEN, C.E. AND VERGUN, P. Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment seeking and non-treatment seeking populations. Addiction 97: 279-292, 2002.
32. MURRAY, C.J., EVANS, D.B., ACHARYA, A. AND BALTUSSEN, R.M. Development of WHO guidelines on generalized cost-effectiveness analysis. Hlth Econ. 9: 235-251, 2000.
33. MURRAY, C.J.L. AND LOPEZ, A.D. (Eds.) The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, Cambridge, MA: Harvard Univ. Press, 1996.
34. NATHAN, P.E. AND GORMAN, J.M. (Eds.) A Guide to Treatments That Work, New York: Oxford Univ. Press, 2002.
35. NEW SOUTH WALES HEALTH DEPARTMENT. NSW Detoxification Clinical Practice Guidelines, Sydney, Australia: New South Wales Health Department, 1999.
36. O'FARRELL, T.J. AND FALS-STEWART, W. Family-involved alcoholism treatment: An update. In: GALANTER, M. (Ed.) Recent Developments in Alcoholism, Vol. 15: Services Research in the Era of Managed Care, New York: Kluwer Academic/Plenum, 2001, pp. 329-356.
37. ORMEL, J., VON KORFF, M., VAN DEN BRINK, W., KATON, W., BRILMAN, E. AND OLDEHINKEL, T. Depression, anxiety, and social disability show synchrony of change in primary care patients. Amer. J. Publ. Hlth 83: 385-390, 1993.
38. PALISADE CORPORATION. @RISK: Advanced Risk Analysis for Spreadsheets, New York: Palisade Corp., 2001.
39. PALMER, A.J., NEESER, K., WEISS, C., BRANDT, A., COMTE, S. AND FOX, M. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol Alcsm 35: 478-492, 2000.
40. PROUDFOOT, H. AND TEESSON, M. Investing in Drug and Alcohol Treatment, Sydney, Australia: National Drug and Alcohol Research Centre, 2000.
41. PROUDFOOT, H. AND TEESSON, M. Who seeks treatment for alcohol dependence? Findings from the Australian National Survey of Mental Health and Wellbeing. Social Psychiat. Psychiat. Epidemiol. 37: 451-456, 2002.
42. ROBINS, L.N. AND REIGER, D.A. (Eds.) Psychiatric Disorders in America: The Epidemiologic Catchment Area Study, New York: Free Press, 1991.
43. SANDERSON, K., ANDREWS, G., CORRY, J. AND LAPSLEY, H. Reducing the burden of affective disorders: Is evidence-based health care affordable? J. Affect. Disord. 77: 109-125, 2003.
44. SANDERSON, K., ANDREWS, G., CORRY, J. AND LAPSLEY, H. Using the effect size to model change in preference values from descriptive health status. Qual. Life Res., in press.
45. STOCKWELL, T., MCLEOD, R., STEVENS, M., PHILLIPS, M., WEBB, M. AND JELINEK, G. Alcohol consumption, setting, gender and activity as predictors of injury: A population-based case-control study. J. Stud. Alcohol 63: 372-379, 2002.
46. TEESSON, M., HALL, W., LYNSKEY, M. AND DEGENHARDT, L. Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing. Aust. New Zeal. J. Psychiat. 34: 206-213, 2000.
47. TONIGAN, J.S., TOSCOVA, R. AND MILLER, W.R. Meta-analysis of the literature on Alcoholics Anonymous: Sample and study characteristics moderate findings. J. Stud. Alcohol 57: 65-72, 1996.
48. WORLD HEALTH ORGANIZATION. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, Geneva, Switzerland: World Health Organization, 1992.
49. WORLD HEALTH ORGANIZATION. Composite International Diagnostic Interview, Version 2.1. Geneva, Switzerland: World Health Organization, 1997.